Want to join the conversation?
Healthcare company $LLY said the US FDA has approved Taltz injection 80 mg/mL for treating moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Taltz will be available in the US beginning in second quarter of 2016.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.